Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 3Other hematologic neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Obesity 3Endometrial Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Opioid-Related Disorders 1Lymphoma, Follicular 1Hyperplasia 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 3mirabegron 1Tablets 1Specimen Handling 1Resistance Training 1Metformin 1Megestrol Acetate 1Hydroquinones 1Counseling 1Caloric Restriction 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Obesity × Tirzepatide × 30 days × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07228741 2026-06-04

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

St. Jude Children's Research Hospital

Phase 2 Recruiting
20 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06485089 2026-05-28

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers

University of Kansas Medical Center

Completed
25 enrolled
Other

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡